|
Valoración de DCF IMMUTEP LIMITADO (IMMP)
AU | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Immutep Limited (IMMP) Bundle
¡Simplifique la valoración de ImmuteP Limited (IMMP) con esta calculadora DCF personalizable! Con las finanzas de Real ImmuteP Limited (IMMP) y las entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de ImmuteP Limited (IMMP) en minutos.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.7 | 2.5 | .1 | 2.2 | 2.4 | 2.2 | 2.0 | 1.8 | 1.7 | 1.6 |
Revenue Growth, % | 0 | -47 | -95.71 | 1957.72 | 9.59 | -8.28 | -8.28 | -8.28 | -8.28 | -8.28 |
EBITDA | -8.4 | -11.1 | -19.8 | -24.6 | -27.7 | -2.2 | -2.0 | -1.8 | -1.7 | -1.6 |
EBITDA, % | -179.76 | -447.75 | -18708.86 | -1128.79 | -1159.44 | -100 | -100 | -100 | -100 | -100 |
Depreciation | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 | 1.1 | 1.0 | .9 |
Depreciation, % | 27.78 | 52.17 | 1211.18 | 58.81 | 52.4 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 |
EBIT | -9.7 | -12.3 | -21.1 | -25.9 | -29.0 | -2.2 | -2.0 | -1.8 | -1.7 | -1.6 |
EBIT, % | -207.54 | -499.92 | -19920.04 | -1187.6 | -1211.84 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 16.4 | 37.4 | 49.8 | 76.8 | 113.1 | 2.2 | 2.0 | 1.8 | 1.7 | 1.6 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 2.1 | 3.8 | 5.2 | 5.0 | 4.7 | 2.0 | 1.8 | 1.6 | 1.5 | 1.4 |
Account Receivables, % | 45.3 | 154.34 | 4915.01 | 227.43 | 196.74 | 89.06 | 89.06 | 89.06 | 89.06 | 89.06 |
Inventories | .0 | -3.5 | -.7 | .0 | .0 | -.9 | -.8 | -.7 | -.7 | -.6 |
Inventories, % | 0.000013357477 | -142.62 | -650.54 | 0.000057049589 | 0 | -40 | -40 | -40 | -40 | -40 |
Accounts Payable | 1.0 | 1.1 | 1.8 | 3.4 | 2.4 | 1.6 | 1.5 | 1.4 | 1.2 | 1.1 |
Accounts Payable, % | 21.9 | 45.99 | 1682.32 | 155.41 | 98.66 | 73.31 | 73.31 | 73.31 | 73.31 | 73.31 |
Capital Expenditure | .0 | .0 | .0 | .0 | -.6 | -.2 | -.2 | -.1 | -.1 | -.1 |
Capital Expenditure, % | -0.25844 | -0.39316 | -13.45 | -1.34 | -24.27 | -7.94 | -7.94 | -7.94 | -7.94 | -7.94 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -9.7 | -12.3 | -21.1 | -25.9 | -29.0 | -2.2 | -2.0 | -1.8 | -1.7 | -1.6 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -9.5 | -9.1 | -23.4 | -23.5 | -29.1 | 1.8 | -1.0 | -1.0 | -.9 | -.8 |
WACC, % | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 |
PV UFCF | ||||||||||
SUM PV UFCF | -.8 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -1 | |||||||||
Terminal Value | -7 | |||||||||
Present Terminal Value | -4 | |||||||||
Enterprise Value | -5 | |||||||||
Net Debt | -100 | |||||||||
Equity Value | 95 | |||||||||
Diluted Shares Outstanding, MM | 1,201 | |||||||||
Equity Value Per Share | 0.08 |
What You Will Receive
- Comprehensive Financial Model: Immutep Limited’s actual data facilitates accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
- Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as trial timelines, patient demographics, and treatment efficacy.
- Instant DCF Valuation: Quickly calculates intrinsic value, NPV, and additional metrics with ease.
- High-Precision Accuracy: Leverages Immutep Limited’s (IMMP) actual financial data for credible valuation results.
- Simplified Scenario Analysis: Evaluate various assumptions and effortlessly compare results.
- Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based IMMP DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other parameters.
- Instant Calculations: The model automatically recalculates Immutep Limited’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial decisions.
Why Choose This Calculator for Immutep Limited (IMMP)?
- User-Friendly Interface: Perfectly crafted for both novices and seasoned users.
- Customizable Parameters: Adjust inputs effortlessly to suit your financial analysis.
- Real-Time Feedback: Monitor immediate changes to Immutep's valuation as you tweak variables.
- Pre-Configured Data: Comes loaded with Immutep's latest financial information for swift evaluations.
- Relied Upon by Experts: Favored by investors and analysts for making data-driven choices.
Who Should Use This Product?
- Finance Students: Discover valuation techniques and apply them using real-time data for Immutep Limited (IMMP).
- Academics: Integrate professional models into your coursework or research focused on Immutep Limited (IMMP).
- Investors: Evaluate your own assumptions and analyze valuation scenarios for Immutep Limited (IMMP).
- Analysts: Enhance your workflow with a pre-built, customizable DCF model tailored for Immutep Limited (IMMP).
- Small Business Owners: Understand how large public companies like Immutep Limited (IMMP) are assessed in the market.
What the Template Contains
- Pre-Filled Data: Includes Immutep Limited’s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Immutep Limited’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.